Category Archives: Daily Alert

Ramipril Section 8

Decisions were released publicly yesterday in two PM(NOC) Section 8 proceedings. After a joint hearing with Justice Hughes, Justice Snider upheld the validity of Section 8 of the Regulations (in 2012 FC 551). She awarded the recovery of losses to Teva (in 2012 FC 552) and Apotex (in 2012 FC 553) on the assumption that an authorized generic and another generic would have enter the market.

Continue reading Ramipril Section 8

Australian High Court on ISP liability for copyright infringed

On Friday, the High Court of Australia dismissed an appeal by content companies in Roadshow Films Pty Ltd v iiNet Limited[2012] HCA 16 (summary) on the basis that under the Australian Copyright Act the ISP was not to be held liable as having authorised infringements by its customers using BitTorrent.

Continue reading Australian High Court on ISP liability for copyright infringed

USSC on Orange Book information

The U.S. Supreme Court issued its decision today in Caraco Pharmaceutical Laboratories, Ltd. v. Novo Nordisk A/S on patent listing requirements in the FDA’s “Orange Book” for patented drugs. Caraco, an ANDA filer, brought a counterclaim in Novo’s Hatch-Waxman infringement action seeking an order that Novo correct patent information in the Orange Book on the basis the patent did not claim a use of the drug.

Continue reading USSC on Orange Book information